{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:46:42Z","timestamp":1790646402909,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001595","name":"Dystonia Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014593","name":"Neurocrine Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013116","name":"Merz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jns.2019.05.010","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T10:41:02Z","timestamp":1557744062000},"page":"57-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Clinical phenotype in carriers of intermediate alleles in the huntingtin gene"],"prefix":"10.1016","volume":"402","author":[{"given":"Daniel","family":"Savitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2019.05.010_bb0005","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2018.09.022","article-title":"Huntington disease: a quarter century of progress since the gene discovery","volume":"396","author":"Testa","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.05.010_bb0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/WNL.0000000000002944","article-title":"Clinical manifestations of intermediate allele carriers in Huntington disease","volume":"87","author":"Cubo","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.05.010_bb0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/mds.21195","article-title":"Autopsy-proven Huntington's disease with 29 trinucleotide repeats","volume":"22","author":"Kenney","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.05.010_bb0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3810\/pgm.2011.09.2466","article-title":"Exploring the correlates of intermediate CAG repeats in Huntington disease","volume":"123","author":"Ha","year":"2011","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.jns.2019.05.010_bb0025","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1212\/WNL.0b013e318294b304","article-title":"Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS","volume":"80","author":"Killoran","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.05.010_bb0030","article-title":"Intermediate CAG repeats in Huntington's disease: analysis of COHORT","volume":"2","author":"Ha","year":"2012","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"10.1016\/j.jns.2019.05.010_bb0035","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/jnnp-2017-317057","article-title":"Leg stereotypy syndrome: phenomenology and prevalence","volume":"89","author":"Lotia","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.05.010_bb0040","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0000000000002958","article-title":"Neurologic features in intermediate allele carriers of Huntington disease","volume":"87","author":"Morrison","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.05.010_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12864-017-3745-z","article-title":"The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model","volume":"18","author":"van Hagen","year":"2017","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jns.2019.05.010_bb0050","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.0423","article-title":"Prevalence of carriers of intermediate and pathological polyglutamine disease-associated alleles among large population-based cohorts","author":"Gardiner","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jns.2019.05.010_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.0216","article-title":"Common premutations in the general population","author":"Hammer","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jns.2019.05.010_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4238\/gmr16029648","article-title":"Intermediate alleles of huntington's disease HTT gene in different populations worldwide: a systematic review","volume":"16","author":"Apolin\u00e1rio","year":"2017","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.jns.2019.05.010_bb0065","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3233\/JHD-160185","article-title":"Phenotype characterization of HD intermediate alleles in PREDICT-HD","volume":"5","author":"Downing","year":"2016","journal-title":"J Huntingtons Dis"},{"key":"10.1016\/j.jns.2019.05.010_bb0070","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1093\/hmg\/ddp242","article-title":"Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset","volume":"18","author":"Swami","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jns.2019.05.010_bb0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/nan.12465","article-title":"Review: somatic mutations in neurodegeneration","volume":"44","author":"Leija-Salazar","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jns.2019.05.010_bb0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/318193","article-title":"Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases","volume":"68","author":"Falush","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jns.2019.05.010_bb0085","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ajmg.b.32618","article-title":"The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population","volume":"177","author":"Kay","year":"2018","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.jns.2019.05.010_bb0090","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s10897-012-9533-7","article-title":"\u201cGrasping the grey\u201d: patient understanding and interpretation of an intermediate allele predictive test result for Huntington disease","volume":"22","author":"Semaka","year":"2013","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.jns.2019.05.010_bb0095","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/ajmg.a.32901","article-title":"Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG)","volume":"149A","author":"Hendricks","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.jns.2019.05.010_bb0100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejmg.2014.11.005","article-title":"A new mutation for Huntington disease following maternal transmission of an intermediate allele","volume":"58","author":"Semaka","year":"2015","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.jns.2019.05.010_bb0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1399-0004.2012.01900.x","article-title":"Recommendations for the predictive genetic test in Huntington's disease","volume":"83","author":"MacLeod","year":"2013","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jns.2019.05.010_bb0110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/cge.12324","article-title":"Evidence-based genetic counselling implications for Huntington disease intermediate allele predictive test results","volume":"85","author":"Semaka","year":"2014","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jns.2019.05.010_bb0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mds.870100116","article-title":"Tourettism associated with Huntington's disease","volume":"10","author":"Jankovic","year":"1995","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.05.010_bb0120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jnnp.2008.170902","article-title":"Late-onset Huntington disease with intermediate CAG repeats: true or false?","volume":"81","author":"Groen","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.05.010_bb0125","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/mds.23623","article-title":"Caudate glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG(33) repeat length in the Huntington's disease gene","volume":"26","author":"Squitieri","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.05.010_bb0130","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/jmedgenet-2013-101796","article-title":"CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease","volume":"50","author":"Semaka","year":"2013","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.jns.2019.05.010_bb0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/ng0494-409","article-title":"Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm","volume":"6","author":"Telenius","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jns.2019.05.010_bb0140","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/mds.25172","article-title":"Huntington's disease: how intermediate are intermediate repeat lengths?","volume":"27","author":"Squitieri","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.05.010_bb0145","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1038\/gim.2014.146","article-title":"American College of Medical Genetics and Genomics Standards and Guidelines for Clinical Genetics Laboratories, 2014 edition: technical standards and guidelines for Huntington disease","volume":"16","author":"Bean","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.jns.2019.05.010_bb0150","doi-asserted-by":"crossref","first-page":"215.e9","DOI":"10.1016\/j.neurobiolaging.2018.11.014","article-title":"HTT gene intermediate alleles in neurodegeneration: evidence for association with Alzheimer's disease","volume":"76","author":"Men\u00e9ndez-Gonz\u00e1lez","year":"2019","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.jns.2019.05.010_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2019.00453","article-title":"Genetic counseling in Huntington\u2019s disease: Potential new challenges on horizon?","volume":"10","author":"Migliore","year":"2019","journal-title":"Front. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19302266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19302266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:46:22Z","timestamp":1758383182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X19302266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":31,"alternative-id":["S0022510X19302266"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.05.010","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical phenotype in carriers of intermediate alleles in the huntingtin gene","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}